Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To understand which medications might work we need to compare these to usual care. Government health advisors will tell us which medications they want us to test. 

 

Each care home will be allocated a particular trial medication. If residents (or, if they lack capacity their legal representative) agree to take part, they will either have their usual care plus a trial medication for 6 weeks, or carry on with their usual care alone. We won’t know the allocation until all the residents in the care home have been asked if they would like to take part. Neither residents (or, if they lack capacity their legal representative), nor the care home, can choose what residents will receive. This will be decided by a computer.

 

If residents (or, if they lack capacity, their legal representative) agree to take part:

  1. Residents (or, if they lack capacity, their legal representatives) will be asked to sign a Consent Form to be part of the trial.
  2. With residents’ (or, if they lack capacity their legal representative’s) permission, we will inform their GP about their participation in this trial. We would also like to access each resident’s medical records, including those held by their GP. We would like information about each resident’s medical history and the medications they are taking. This will help us understand which of the trial medications they can have.
  3. Care home staff will complete two questionnaires with details about residents’ health. Residents with capacity will also be asked to complete these questionnaires. Care home staff can help with this.
  4. Residents will be allocated to receive either:
    1. usual care plus a trial medication OR
    2. usual care alone
  5. The researchers will collect some information from each care home about the residents’ use of the trial medication and whether this has made a difference to their health. We will also collect some information from national databases and trusted third parties about each resident’s general health.